BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2335046)

  • 1. Bayesian forecasting of serum gentamicin concentrations in intensive care patients.
    Rodvold KA; Pryka RD; Kuehl PG; Blum RA; Donahue P
    Clin Pharmacokinet; 1990 May; 18(5):409-18. PubMed ID: 2335046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian forecasting of gentamicin pharmacokinetics in pediatric intensive care unit patients.
    Kraus DM; Dusik CM; Rodvold KA; Campbell MM; Kecskes SA
    Pediatr Infect Dis J; 1993 Sep; 12(9):713-8. PubMed ID: 8414796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of gentamicin concentrations in neonates and infants using a Bayesian pharmacokinetic model.
    Rodvold KA; Gentry CA; Plank GS; Kraus DM; Nickel E; Gross JR
    Dev Pharmacol Ther; 1993; 20(3-4):211-9. PubMed ID: 7828456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrations.
    Rodvold KA; Pryka RD; Garrison M; Rotschafer JC
    Ther Drug Monit; 1989; 11(3):269-75. PubMed ID: 2728085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian forecasting of serum vancomycin concentrations with non-steady-state sampling strategies.
    Rodvold KA; Rotschafer JC; Gilliland SS; Guay DR; Vance-Bryan K
    Ther Drug Monit; 1994 Feb; 16(1):37-41. PubMed ID: 8160252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
    Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
    Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a Bayesian program with three microcomputer programs for predicting gentamicin concentrations.
    Godley PJ; Black JT; Frohna PA; Garrelts JC
    Ther Drug Monit; 1988; 10(3):287-91. PubMed ID: 3176104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian models.
    Pryka RD; Rodvold KA; Garrison M; Rotschafer JC
    Ther Drug Monit; 1989; 11(4):450-4. PubMed ID: 2741194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of six gentamicin nomograms using a bayesian parameter estimation program.
    Thomson AH; Campbell KC; Kelman AW
    Ther Drug Monit; 1990 May; 12(3):258-63. PubMed ID: 2349609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics: development of a medical intensive care unit-specific gentamicin dosing nomogram.
    Watling SM; Kisor DF
    Ann Pharmacother; 1993 Feb; 27(2):151-4. PubMed ID: 8439687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of aminoglycoside pharmacokinetics in postpartum patients using Bayesian forecasting.
    Cropp CD; Davis GA; Ensom MH
    Ther Drug Monit; 1998 Feb; 20(1):68-72. PubMed ID: 9485558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two methods to obtain a desired first isepamicin peak in intensive care patients.
    Fauvelle F; Coulaud JM; Lecointre K; Tardy D; Poussel JF; Trape G
    Fundam Clin Pharmacol; 2001 Apr; 15(2):151-6. PubMed ID: 11468025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the use of Bayesian analysis in the optimization of gentamicin therapy from the commencement of dosing.
    Chrystyn H
    Drug Intell Clin Pharm; 1988 Jan; 22(1):49-53. PubMed ID: 3349920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of various creatinine clearance formulas in predicting gentamicin elimination in patients with low serum creatinine.
    Reichley RM; Ritchie DJ; Bailey TC
    Pharmacotherapy; 1995; 15(5):625-30. PubMed ID: 8570436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin.
    Burton ME; Chow MS; Platt DR; Day RB; Brater DC; Vasko MR
    Clin Pharm; 1986 Feb; 5(2):143-9. PubMed ID: 3754192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural network predicted peak and trough gentamicin concentrations.
    Brier ME; Zurada JM; Aronoff GR
    Pharm Res; 1995 Mar; 12(3):406-12. PubMed ID: 7617529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of gentamicin. Use of the nonparametric expectation maximisation (NPEM) algorithm.
    Kisor DF; Watling SM; Zarowitz BJ; Jelliffe RW
    Clin Pharmacokinet; 1992 Jul; 23(1):62-8. PubMed ID: 1617859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of pharmacokinetic dose determination of gentamicin in geriatric patients.
    Lackner TE; Birge S
    DICP; 1990 Jan; 24(1):29-32. PubMed ID: 2301187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic parameters of vancomycin in critically ill patients.
    Llopis-Salvia P; Jiménez-Torres NV
    J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.